The recall includes more than 1,500 devices distributed to customers from October 2021 to January 2023. 

The drug's manufacturer said it is working with retailers to get the drug on U.S. shelves and online for purchase by late summer.

If great power obligates its wielder to exercise great responsibility, those advancing AI in healthcare are up to their necks in duty.

A common abortion pill, mifepristone, is still in grave danger of being pulled off the market. 

The recommendation updates the FDA’s emergency use authorizations for the Moderna and Pfizer-BioNTech COVID-19 vaccines.

The new findings come after Moderna accused other pharmaceutical companies of stealing its mRNA technology for COVID-19 vaccines.

The Supreme Court has stepped in to block a Texas-based federal judge’s order that pulled back the approval of mifepristone.

“The Justice Department strongly disagrees with the Fifth Circuit’s decision in Alliance for Hippocratic Medicine v. FDA to deny in part our request for a stay pending appeal,” Attorney General Merrick Garland said April 13.